Quick Links

 Clinical Cancer Genetics
City of Hope’s Division of Clinical Cancer Genetics (CCG) is a multidisciplinary consortium of clinical, research and education initiatives designed to improve identification, counseling, and treatment of people who are at increased genetic risk of developing cancer. Screening and prevention, an integral part of all of City of Hope’s disease management programs, are the major focus of the Division’s efforts.

One of the divisions of the Department of Population Sciences, CCG also benefits from close collaborations with the Department of Medical Oncology & Therapeutics Research and the Beckman Research Institute.
 
 Cancer Screening & Prevention Programsm (CSPP)

In light of a growing body of research confirming that many common cancers, including breast, ovarian, and colorectal cancer, are hereditary, the Division of Clinical Cancer Genetics’ Cancer Screening & Prevention ProgramSM helps people understand their personal cancer risk profiles, offering a comprehensive cancer risk assessment that takes into account family history and genetics, along with environmental and lifestyle factors. With this information, people can take proactive steps to “outsmart cancer.”
CCG Research Program

Clinical cancer genetics research at City of Hope investigates multiple approaches that utilize the latest findings in cancer genetics in order to improve the prevention, treatment, and support of those with hereditary cancers.

Cancer Genetics Education Program (CGEP)

The division’s Cancer Genetics Education Program (CGEP) offers courses and self-teaching tools designed to further health care professionals’ understanding of cancer genetics. Major initiatives include the Cancer Genetics Career Development Program (CGCDP), the Intensive Course in Cancer Risk Assessment (IC), and the Clinical Cancer Genetics Community of Practice (COP). In addition, CGEP staff speak to medical groups, hospital medical staffs and other community health care professionals. The program is supported in part by the National Cancer Institute and the California Research Program.

 Search
Go!
Advanced Search Options
News & Publications Search
Mission Statement
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

 Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Programsm, call 626-256-8662, ext. 2.

 Cancer Genetics News
© 2012 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.